PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER- FRENCH HEALTH CARE PAYER PERSPECTIVE
May 1, 2011, 00:00
10.1016/j.jval.2011.02.886
https://www.valueinhealthjournal.com/article/S1098-3015(11)01025-4/fulltext
Title :
PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER- FRENCH HEALTH CARE PAYER PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01025-4&doi=10.1016/j.jval.2011.02.886
First page :
A159
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
354